Related stories
FDA Approves AstraZeneca’s Klygefa for Generalized Myasthenia Gravis
The FDA approved Klygefa (gefurulimab) for adults with generalized myasthenia gravis who are anti-acetyl…
M impact | REGULATION | Nov 16, 2026, 12:18 PM UTC
Summit shares drop after US FDA declines to approve lung cancer drug
Summit shares drop after US FDA declines to approve lung cancer drug Nov 16 (Reuters) - Shares of Su
L impact | REGULATION | Nov 16, 2026, 11:44 AM UTC
FDA Issues Complete Response Letter for Summit Therapeutics’ Ivonescimab BLA
Summit Therapeutics said the FDA will not approve its ivonescimab application in its current form, citing insufficient evidence of effectiveness without a statistically significant
M impact | REGULATION | Nov 16, 2026, 11:27 AM UTC
EU disburses another €1.7 billion to Ukraine
The EU disbursed another €1.7 billion to Ukraine for defence spending.
M impact | REGULATION | Nov 16, 2026, 11:18 AM UTC
EMA Committee Recommends Expanding Use of ViiV Healthcare HIV Drugs
GSK's majority-owned ViiV Healthcare said Monday that an EMA committee recommended expanding use of its HIV drugs.
L impact | REGULATION | Nov 16, 2026, 11:16 AM UTC
EU Approves Nearly €8 Billion Aid Payment for Ukraine
The European Union approved an aid payment of just under €8 billion ($8.8 billion) for war.
M impact | REGULATION | Nov 16, 2026, 11:15 AM UTC